Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) antibody-drug conjugate (ADC) technology, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:
•Jefferies 2013 Global Healthcare Conference 11:30 am ET, June 5, 2013 in New York, NY Presenter: Daniel Junius, President and CEO
Help employers find you! Check out all the jobs and post your resume.
ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) antibody-drug conjugate (ADC) technology, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:
•Jefferies 2013 Global Healthcare Conference 11:30 am ET, June 5, 2013 in New York, NY Presenter: Daniel Junius, President and CEO
Help employers find you! Check out all the jobs and post your resume.
